Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	81
Overall Study	STARTED	0.25% DHEA	87
Overall Study	STARTED	0.50% DHEA	87
Overall Study	Safety Population	Placebo	80
Overall Study	Safety Population	0.25% DHEA	86
Overall Study	Safety Population	0.50% DHEA	87
Overall Study	ITT Population	Placebo	77
Overall Study	ITT Population	0.25% DHEA	79
Overall Study	ITT Population	0.50% DHEA	81
Overall Study	COMPLETED	Placebo	72
Overall Study	COMPLETED	0.25% DHEA	74
Overall Study	COMPLETED	0.50% DHEA	76
Overall Study	NOT COMPLETED	Placebo	9
Overall Study	NOT COMPLETED	0.25% DHEA	13
Overall Study	NOT COMPLETED	0.50% DHEA	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01256684/flow